Professional Documents
Culture Documents
TABLE OF CONTENTS
Semester Overview
Schedules
SEMESTER 1
SEMESTER 2
Exam Preparation p. 57
Program Overview
Mission
Enable better global health outcomes for infants and children with heart disease
Vision
Cultivate excellence in health care teams and systems
Goals
Enhance learning through inclusion and innovation
Objective 1: Better able to differentiate between normal and abnormal paediatric cardiac anatomy
and physiology.
Objective 2: Better prepared to use specialized paediatric cardiac acute-care clinical skills to
evaluate and diagnose infants and children with congenital and acquired heart disease.
Objective 3: Better prepared to provide short-term acute treatment and support to infants, children
and families affected by congenital and acquired heart disease.
Objective 4: Better prepared to provide long-term treatment and support to infants, children and
families affected by congenital and acquired heart disease.
Program Overview
This two-semester program offers a livestream webinar series for 6.5 hours per week, over 33 weeks.
The program consists of 240 hrs of learning, 200 sessions and is facilitated by 100 plus SickKids
interprofessional faculty.
The program offers a variety of learning modalities including didactic lectures, independent studies,
small group work, learner-led presentations, and seminar-based discussions. Facilitators employ
active learning strategies using audience response systems, gamification, case studies, problem-
based learning discussions, panel discussions, question, and answer sessions. This helps
participants further develop their technical, cognitive, collaborative, and affective professional abilities
Along with our subject matter expert team, we are delighted to present this comprehensive evidence-
based program and look forward to learning with you over the next eight months.
Connecting to Sessions
Recording
All sessions are recorded and uploaded to the Attendee Hub to allow attendees to REPLAY sessions.
If you do not wish to be recorded, you have the option to hide your profile visibility, and set your mic
and video camera set to OFF.
3|Page
Park, M., Mehrdad, S. (2021). Park’s The Pediatric Cardiology Handbook, 6 th Edition. Elsevier,
Philadelphia, US. Paperback ISBN: 97803237168660
Jones M, Klugman D, Fitzgerald, R. Kohr L, Berger J, Costello J, Bronicki R. 2018. Pediatric Cardiac
Intensive Care Handbook. Pediatric Cardiac Intensive Care Books, Washington D.C. Pediatric
Cardiac Intensive Care Society website: PCICS Publications
We look forward to two very exciting upcoming semesters and wish you every success in the course
as you translate your learning into extraordinary patient and family quality care.
Program Directors
Cecilia St. George-Hyslop, BScN Gen, RN, M Ed, CNCCPC
cecilia.hyslop@sickkids.ca; Phone +1 (416-813-6499
4|Page
2021 Semester 1
December 3rd Polling Practice: Challenge Your Knowledge and Skills – Case Based
Applications
2022 Semester 2
April 8th Polling Practice: Challenge Your Knowledge and Skills – Case Based
Applications
5|Page
SEMESTER 1 - OVERVIEW
Time: 09:00-4:30 The livestream agenda is synchronized with Eastern Daylight or Eastern Standard
Time.
Location: Online via Zoom. Presenting location, The Hospital for Sick Children, 555 University
Avenue, Toronto, Canada, M5G 1X8
For livestream schedule, please refer to the Session Schedule – Semester 1 later in this syllabus.
• Obstructive lesions:
o Aortic Stenosis (AS), Pulmonary Stenosis (PS), Coarctation of the Aorta (AO);
Atrioventricular valve stenosis – Mitral Stenosis (MS), Tricuspid Stenosis (TS); Cor
Triatriatum
• Cyanotic lesions:
o Complete Transposition of the Great Arteries (D-TGA), Truncus Arteriosus; Single
Ventricle - HLHS; Tetralogy of Fallot (TOF), Tricuspid Atresia (TA), Pulmonary Atresia
(PA), Total Anomalous Pulmonary Venous Return (TAPVR), Unbalanced AVSD
6|Page
7|Page
● Describe the role of the family within the health care team in supporting their infant/child
● List principles of family centred care
● Identify strategies to prevent and manage conflict arising between families and the health care
team
SEMESTER 2 - OVERVIEW
Time: 09:00-4:30 The livestream agenda is synchronized with Eastern Daylight or Eastern Standard
Time.
Location: Online via Zoom. Presenting location, The Hospital for Sick Children, 555 University
Avenue, Toronto, Canada, M5G 1X8
For livestream schedule, please refer to the Session Schedule – Semester 2 later in this syllabus.
Semester 2 concentrates on the more complex congenital cardiac defects, particularly children with
single ventricular physiology. There is continued focus on the acute care stage of intraoperative,
postoperative repair of congenital cardiac repair. Recognizing that for some infants and children, a
shortened lifespan is the natural outcome, there is an in-depth look at the phases of palliation, death
and dying. An analysis of long-term outcomes takes learners into the transitional process of
teenagers, from an acute care paediatric hospital into the adult world of congenital heart disease.
Using bioethical principles, learners have the opportunity to debate a variety of ethical issues
pertaining to paediatric cardiology.
Learning about complex congenital heart defects is facilitated subject matter experts via didactic
sessions and through the live webcast heart lab series by Dr. David Chiasson and recorded video series
by Dr. Robert Anderson These presentations provide an in-depth look at a variety of congenital heart
defects by reviewing the anatomic morphology using segmental analyses.
8|Page
Dr. Robert Anderson video series: An additional and optional resource available to participants to
supplement learning.
Semester 2 Objectives
Upon completion of semester two, learners will:
• Identify key features of fetal and paediatric echocardiography
• Analyze advanced hemodynamic monitoring data from invasive and non-invasive monitoring
devices
• Demonstrate a systematic approach to interpreting 15 lead EKG’s
• Describe the anatomy and pathophysiology of complex congenital cardiac defects - single
ventricle physiology: hypoplastic left heart syndrome (HLHS), mitral atresia, tricuspid atresia,
hypoplastic right heart syndrome (HRHS), double inlet left ventricle (DILV), double outlet right
ventricle(DORV), interrupted aortic arch ( (IAA) , pulmonary atresia (PA), aortic atresia (AA);
Other complex defects include congenitally corrected transposition of the great arteries (cc-
TGA), Ebstein’s Anomaly, truncus arteriosus, vascular rings and slings, COR triatriatum, and
atrial isomerism
• Compare and contrast complex cardiac lesions from the Dr. David Chiasson’s morphology
heart lab series
• Discuss the care of cardiac patients undergoing complex surgical procedures (Yasui, DKS,
Kawashima, Double switch, Hybrid, Coles Procedure)
• Outline intra-operative and postoperative management of patients undergoing surgical repair
• Outline the usage of various pharmacological agents (Vasopressin, Phentolamine, Clonidine,
Sildenafil, Prostacyclin, and corticosteroids) in the acute management of postoperative
cardiac surgical patients
• Synthesize the strategies used to effectively manage the postoperative cardiac patient
• Discuss postoperative complications such as stroke, seizures, venous thrombosis
• State key considerations when caring for patients undergoing cardiac transplantation.
Compare and contrast ventricular assist devices: Cardiopulmonary Bypass, ECMO, Berlin
Heart, Heartmate3, Syncardia Total Artificial Heart, Impella and Centrimag
• Review the issues surrounding complex care needs and children living with chronic care
needs and the apply the principles of “chronicity” theory
• Identify future complications that may arise as a result of having a complex congenital cardiac
defect.
• Describe considerations of care as children transition from an acute paediatric hospital to
adult health care settings
• Discuss the Interprofessional collaborative roles of the Palliative Care Team in supporting
9|Page
patients and their families through the stages of palliation, dying and death
• Describe interventions the health care steam in supporting families through these phases.
• Argue the pro or con side of an ethical debate using sound ethical principles
• Uses evidence-based practice in discussions about cardiac clinical issues and during case
reviews.
10 | P a g e
11:30 Video Series Dr. Robert Anderson “Normal Cardiac Anatomy and
Sequential Analysis”
11 | P a g e
11:30 Dr. Haley How Do I Manage Heart Failure in the Critical Care
Christian © Unit?
12 | P a g e
HEART FAILURE
Week 3 09:00 Laura Genetics & Children with Syndromes Associated with Park, M. p. 308-319
Sept 17, Zahavich © Congenital Heart Defects
2021 Principles of genetics, genetic screening and
(EDT) dysmorphology. Family support and genetic
counselling
10:00 Laura Syndromes Associated with Congenital Heart Park, M. p. 308-319
Zahavich Defects
©
13 | P a g e
14 | P a g e
ECG INTERPRETATION
15 | P a g e
16 | P a g e
17 | P a g e
CARDIAC RESUSCITATION
13:00 Winnie Seto Resuscitation Medications in Infants and Children Park, M. p. 552-582
©
16:00 Dr. Seth Gray Analyzing Trends in Cardiac Arrest: What T3 Can
© Tell Us About Cardiac Resuscitation
18 | P a g e
19 | P a g e
20 | P a g e
Week 11 09:00 Christine Pacemaker Therapy: Recognizing and Managing Park, M. p. 358-366
Nov 12, Chiu-Man © Complications
2021
10:00 Christine Pacemaker Therapy: Practice/Strip Analysis
(EST) Chiu-Man ©
10:30 Break Break
11:00 Dr. Leo Hemostasis in Children with Cardiac Conditions
Brandao ©
12:00 Lunch Lunch
21 | P a g e
22 | P a g e
23 | P a g e
• Defibrillation, Cardioversion,
Transcutaneous Pacing
• Pacemakers
24 | P a g e
Week 15 09:00 Laura Genetics of Cardiomyopathy & the Role of the Heart Park, M. p. 247-260
Dec 10, Zahavich © Failure Team
2021
09:30 Dr. Aamir Cardiomyopathies - Dilated, Hypertrophic,
(EST) Jeewa © Restrictive, Non-Compaction, Arrhythmogenic Right
Ventricular Cardiomyopathy (UHL anomaly):
Evaluation and Management
11:00 Dr. Andrew Infection Risks and Susceptibilities in Cardiac Park, M. p. 423-431
Helmers © Patients: Preventing Nosocomial Infections
25 | P a g e
26 | P a g e
27 | P a g e
28 | P a g e
Week 3 09:00 Cecilia Hyslop © Paediatric 15 Lead ECG’s: A Map for All Ages
Jan 21,
2022 10:30 Break Break
(EST) 11:00 Cecilia Hyslop © Paediatric 15 Lead ECG’s: A Map for All Ages
13:00 Cecilia Hyslop © Paediatric 15 Lead ECG’s: A Map for All Ages
15:00- Cecilia Hyslop © Paediatric 15 Lead ECG’s: A Map for All Ages
16:30
29 | P a g e
Week 4 0900 Dr. Michael Approach to the 15 Lead ECG Park, M. p. 38-69
Jan 28, Fridman ©
2022
10:00 Dr. Mjaye Mazwi Double Outlet Right Ventricle (DORV)
(EST) ©
11:00 Dr. Luc Mertens © Paediatric Echocardiography: Normal and Park, M. p. 79-95
Abnormal Hearts Park, M. p. 544-
550
12:00 Lunch Lunch
30 | P a g e
31 | P a g e
32 | P a g e
Week 7 09:00 Cecilia Hyslop © Postoperative Care: Hours After the Park, M. p. 483-
Feb 18, Operating Room 505
2022
10:30 Break Break
(EST)
11:00 Karen Dryden- Conflict Resolution: Strengthening Partnerships
Palmer © and Building Relationships in Times of Stress
33 | P a g e
CARDIAC TRANSPLANTATION
34 | P a g e
(EST) 10:00 Dr. Alex Floh © Hypoplastic Left Heart Syndrome: Park, M. p. 483-
Postoperative Management of 505
– Post Norwood/RV-PA Shunt and
Hybrid
35 | P a g e
11:30 Andrea Pisesky © Current Anticoagulation Practice for Single Park, M. p. 552-
Ventricle Population 582
36 | P a g e
37 | P a g e
38 | P a g e
11:30 Dr. Roxanne Low Cardiac Output Syndrome and Early Post-
Kirsch © 0perative Management
● Hemodynamic Interpretation
● VAD: Heartmate3
39 | P a g e
Week 14 09:00 Dr. Alex Floh © Fluid and Electrolytes: Interpreting Serum
April 8, Laboratory Results
2022
10:30 Break Break
40 | P a g e
41 | P a g e
42 | P a g e
43 | P a g e
Purpose
The purpose of this learning activity is to develop a greater understanding of various CHDs. These can
be categorized into the following:
• Left to right shunt lesions: Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD),
Patent Ductus Arteriosus (PDA), Endocardial Cushion Defects (AVSD)
• Obstructive lesions: Aortic Stenosis (AS), Pulmonary Stenosis (PS), Coarctation of the Aorta
(AO); Atrioventricular Valve stenosis, Mitral Stenosis (MS), Tricuspid Stenosis (TS); Cor
Triatriatum; Valvular regurgitation lesions: Mitral Regurgitation (MR), Tricuspid Regurgitation
(TR), Aortic Regurgitation (AR), Pulmonary Regurgitation (PR)
• Cyanotic lesions: Complete Transposition of the Great Arteries (D-TGA), Truncus Arteriosus;
Single Ventricle - HLHS; Tetralogy of Fallot (TOF), Tricuspid Atresia (TA), Pulmonary Atresia
(PA), Total Anomalous Pulmonary Venous Return (TAPVR), Unbalanced AVSD
Method
Choose a congenital heart defect to present in class. The presentation should include anatomy and
pathology of the congenital heart disease; clinical presentation and manifestations, medical and
surgical management, complications and future considerations (outcomes/care needs). The
presentation may take on any format you are encouraged to be creative in your approach.
Presentations are expected to start and end on time. Depending on the number of participants in the
program, learners may be asked to co-present with a colleague.
Feedback
To further your development, you will be provided with written constructive feedback based on the
rubric below. There is no grade attached to this assignment. Learners will receive feedback based
on the following rubric.
44 | P a g e
CHD Rubric: Modified from Nursing Continuing Education: Instructor Resource Package: Evaluation
& Measurement. 2nd Edition: George Brown College, Pat Marten-Daniel, Henk Demeris. 16/03/05
45 | P a g e
CASE PRESENTATION
Purpose
The purpose of this learning activity is to integrate and apply the relevant principles and curriculum
learned in the course to a retrospective case study.
Method
Choose a child and family that you have provided care for. Learners must protect patient Private
Health Information when collecting patient information for the purpose of the case study.
Your presentation may take any format and you are encouraged to be creative your approach.
Presentations are expected to start and end on time. Depending on the number of participants in the
program, you may be asked to co-present with a colleague.
Feedback
To further your development, you will be provided with written constructive feedback based on the
rubric below. There is no grade attached to this assignment.
46 | P a g e
CHD Rubric: Modified from Nursing Continuing Education: Instructor Resource Package: Evaluation
& Measurement. 2nd Edition: George Brown College, Pat Marten-Daniel, Henk Demeris. 16/03/05
47 | P a g e
Purpose
The purpose of this asynchronous e-learning activity is to enrich your understanding of various
medications such as vasoconstrictors, vasodilators, inotropes, antiarrhythmics and diuretics used in
the therapeutic management of infants and children with congenital and acquired heart disease.
Upon completion of this independent pharmacy assignment, you will have a good understanding of
the indications, mechanism of action, pediatric dosage, administration, drug compatibility and side
effects of those medications used in paediatric cardiology. This exercise will prepare you for Semester
2, where you will work through hemodynamic cases, and through appreciating the risks and benefits
of each, you will suggest suitable drugs for the management of the conditions presented.
Method
This pharmacology module is an independent open-book learning activity consisting of single-best
answer multiple choice questions. You are encouraged to use drug references as you normally would
in clinical practice to answer the questions, rather than using the information from speakers’ course
lectures.
Resources used for this assignment may include online resources, journal articles, and or pharmacy
texts that include paediatric content. References should be recent i.e. within the last 5 years
• Lexicomp
• Lexicomp Paediatric and Neonatal Dosage Handbook
• The SickKids Formulary
• UpToDate
• CPS - Compendium of Pharmaceuticals and Specialties (Canadian Pharmacy Association)
• AHFS – Pharmacologic-Therapeutic Classification – AHFS Drug Information
For this assignment due date, refer to Summary of Important Dates in the course syllabus.
48 | P a g e
ETHICAL DEBATE
Purpose
The purpose of this learning activity it to provide you with an opportunity to develop a clear
understanding of bioethical principles and be able to deconstruct or “unpack” a complex clinical issue
experienced in the setting of paediatric cardiology. You will gain a better understanding of the role of
the bioethics team and the complexities of bioethical decisions.
Method
Choose an ethical topic that is of interest to you and relevant to the subspecialty of pediatric cardiology.
The format will be debate style where pro and con arguments will be presented to the group.
Appropriate references should be included. Presenters should refer to their professional Code of
Ethics for example, the Code of Ethics from the Canadian Nurses Association (CNA) and or any other
resource for ethical standards.
This assignment is designed to integrate all aspects of theory, observation and clinical practice as it
relates to ethical issues and principles.
You will have approximately 30 minutes to present the pro and con arguments of your topic (approx.15
minutes for pro and 15 minutes for con). All presentations should begin and end on time. A list of
references should be included.
o Best interests (weigh harms and benefits, preserving an open future, quality of life,
quality of death)
o Respect for persons (autonomy, truth telling, privacy, confidentiality, transparency)
o Justice (accountability, weighing harms and benefits, treating like cases alike, non-
discrimination on the basis of ethically irrelevant criteria, cost-benefit analysis,
disclosure of error, defensible resource allocation)
o Collaborative decision making
2. Health care professionals should be able to conscientiously object / withdraw from the planned
care for a patient, where they consider the care to be too aggressive and not in the patient's best
interests.
3. A capable 14-year-old does not have sufficient life experience to make serious decisions related
to his/her own health care.
8. "Best interests" is too much of culturally defined term to be useful in a clinical setting.
9. Before any major cardiac surgery in a young child, clinicians should have a frank discussion with
parents about “what if things do not go as hoped”.
10. Parents should not be told of a form of treatment which is not likely to benefit their child.
11. Parents should be given outcome measures in percentages for each surgery based on my
hospital’s experience.
12. Procedures should be considered standard of care in full term infants before they are attempted
in neonates.
13. Parents should be required to meet with palliative care prior to any cardiac transplant.
50 | P a g e
16. Should we use our societies/government resources to treat children from other countries?
Feedback
In order to further your development, you will be provided with written constructive feedback based on
the rubric below. There is no grade attached to this assignment.
Indicator Criteria
Criteria Below Standard Meets Standard Exceeds Standard
Understanding of Team did not show Team seemed to Team clearly understood
Topic adequate understanding understand the main the topic in-depth and
of the topic points of the topic and presented information
presented those with ease confidently and
convincingly
Clear Introduction Opening statements Opening statements Opening statement
and Conclusion minimally outlines outlines most arguments; successfully frames the
arguments; closing closing comments do not issues; closing comments
remarks restates opening reflect all the remarks summarizes many
remarks made during the debate arguments made in the
debate
Use of Argument Team makes minimal use Team uses some appeals Team uses logical,
and Counter of persuasive appeals. to make arguments more emotional and ethical
Arguments: Debate arguments less persuasive. Arguments appeals to enhance
Presents with clear, relevant, strong generally clear arguments. Arguments
clarity, accuracy clear, relevant, strong
and relevancy
Use of Points supported with Most points supported Major points adequately
Facts/Statistics vague or irrelevant with facts, statistics and/or supported with relevant
Reference to ethical information or not at all. examples, but relevance facts, statistics, and or
literature of some was questionable examples.
Use of relevant Statements, responses Most statements and Strong use of ethical
ethical principles poorly reflected use of responses used ethical principles and theory in
and theory ethical principles and principles and theory. arguments. Refers to
theory. Minimal reference Refers to ethical literature ethical literature most of
to ethical literature some of the time the time
Presentation Some team members Team sometimes used Team consistently used
Confidence, were not able to keep gestures, eye contact, gestures, eye contact,
enthusiasm, clear attention of audience. confident tone of voice confident tone of voice
speech and level of enthusiasm in and level of enthusiasm in
a way to keep attention of a way to keep attention of
audience audience
COMMENTS:
Debate Rubric: Modified from Nursing Continuing Education: Instructor Resource Package:
Evaluation & Measurement. 2nd Edition: George Brown College, Pat Marten-Daniel, Henk Demeris.
16/03/05
51 | P a g e
LEARNER REFLECTIONS
Method
At the end of Semester 1 & 2, you are asked to submit a 250-word reflection (approximately ½ page)
pertaining to your professional development during this course. You may use any of the professional
abilities listed below to help guide your reflection. Consider the roles you play within your discipline,
the multiple areas of practice you touch, all of the people you influence, and the patients and families
you care for.
1. Technical
2. Cognitive
3. Collaborative
4. Affective
52 | P a g e
EXAM REVIEW
Purpose
The purpose of the summative assessments (midterm and final examinations) is to evaluate your
learning at the end of the instructional periods outlined below. These exams assess your knowledge,
skill acquisition and clinical judgment as they apply learning to clinical scenarios presented within
questions pertaining to the care of children with congenital and acquired heart disease.
Please find below, information that you may find helpful in preparing for the midterm and final
examinations.
Method
In Semester 1, the midterm and final examinations are each worth 40% of the final mark.
In Semester 2, the midterm and final examinations are each worth 50% of the final mark.
The exam format for all exams will include single best answer multiple choice questions. The typical
number of questions is ~40-50 and it usually takes 1-1.5 hrs to complete. You are welcome to access
and utilize electronic resources during these exams. For example, learners may wish to reference the
required course resource, drug information resources, and recorded presentations.
Semester 2 Midterm Week 1 (Jan 7, 2022) - Week 8 (Feb 25, 2022) 1.5 hours
Exam inclusive
50%
Final Exam Week 9 (March 4, 2022) - Week 15 (April 22, 1 hour
50% 2022) inclusive
The majority of the questions are derived from class content. Recorded Zoom presentations and
presenter PowerPoints can be accessed on the shared OneDrive for the purpose of review.
It is recommended that you review the relevant sections of the required course resource (reference
provided below) to supplement your understanding of course concepts.
Park, Myung. (2021). The Pediatric Cardiology Handbook. Sixth Edition. Mosby Elsevier,
Philadelphia.
53 | P a g e